AKR1B10 and lung carcinoma: AKR1B10 was reported to be upregulated in liver cancer (23, 49–51), lung cancer (27, 28), breast cancer (25), oral cancer (30–32), pancreatic cancer (52), cervical cancer (53) and papillary renal cell carcinoma (54).